Belarus vs Europe (WHO region): Previously treated cases tested for RR-/MDR-TB
Belarus
100.0%
in 2024
Europe (WHO region)
90.0%
in 2024
Belarus rank
1st
Europe (WHO region) rank
2nd
Previously treated cases tested for RR-/MDR-TB over time
- Belarus
- Europe (WHO region)
How they compare
Belarus currently reports 100.0% against 90.0% in Europe (WHO region), a difference of 10.0%.
That makes Belarus's figure about 1.1 times Europe (WHO region)'s.
Across all 19 years both countries report, Belarus has been ahead every year.
Belarus ranks 1st and Europe (WHO region) ranks 2nd of 180 countries.
Belarus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belarus | Europe (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 23.2% | 76.8% | Belarus |
| 2010s | 90.7% | 57.7% | 33.0% | Belarus |
| 2020s | 100.0% | 93.8% | 6.2% | Belarus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Belarus or Europe (WHO region)?
- Belarus, at 100.0% against 90.0% in Europe (WHO region) as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Belarus and Europe (WHO region)?
- 10.0%, with Belarus ahead.
- How many years of comparable data are there for Belarus and Europe (WHO region)?
- 19 years are reported by both, from 2006 to 2024.
- How do Belarus and Europe (WHO region) rank globally for previously treated cases tested for rr-/mdr-tb?
- Belarus ranks 1st and Europe (WHO region) ranks 2nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.